6505--NEW IDIQ - NON-PET Radiopharmaceuticals For Ordering periods from FY25 through FY29
ID: 36C26125R0033Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OF261-NETWORK CONTRACT OFFICE 21 (36C261)MATHER, CA, 95655, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0c86b12d842b408d8d1d36240fc5a7fc/view
Timeline
    Description

    The Department of Veterans Affairs is preparing to issue a Request for Quote (RFQ) for NON-Positron Emission Tomography (PET) Radiopharmaceuticals intended for the VA Palo Alto Healthcare System. This procurement will cover ordering periods from Fiscal Year 2025 through Fiscal Year 2029 and is categorized under NAICS code 325412, emphasizing the importance of specialized radiopharmaceuticals in providing healthcare services to veteran patients. The RFQ is an open market solicitation aimed at awarding a single firm-fixed price contract, with solicitation documents expected to be available around February 14, 2025, and responses due by 12:00 PM Pacific Time on February 28, 2025. Interested parties can direct inquiries to Contracting Officer Edward Hunter at edward.hunter@va.gov or by phone at (702) 791-9000.

    Point(s) of Contact
    Yasemin Akman-LloydContract Specialist
    Yasemin.Akman-lloyd@va.gov
    Files
    Title
    Posted
    36C26125R0033.docx
    The Department of Veterans Affairs is preparing to issue a Request for Quote (RFQ) for NON-Positron Emission Tomography (PET) Radiopharmaceuticals, intended for the VA Palo Alto Healthcare System. This pre-solicitation announcement outlines that the procurement will cover ordering periods from FY25 through FY29 and is categorized under NAICS code 325412. The RFQ is considered an open market solicitation, with the intention to award a single firm-fixed price contract. Solicitation documents are expected to be available around February 14, 2025, with responses due by 12:00 PM Pacific Time on February 28, 2025. Interested parties can direct their inquiries to Contracting Officer Edward Hunter via email. This initiative underlines the VA's commitment to facilitating healthcare services through the procurement of specialized radiopharmaceuticals, addressing the needs of veteran patients.
    36C26125R0033 Attachement 1 - Price-Cost Schedule for Usage.xlsx
    The document outlines a comprehensive price-cost schedule related to the procurement of various radiopharmaceuticals for fiscal years 2025 to 2029 under a five-year contract. It details the items offered, which include isotopes like Tl-201, Ga-67, I-123, I-131, In-111, and multiple forms of Tc99m, alongside their respective unit of measure (UOM), quantity (QTY) per unit, and estimated costs per entity (EA). Each listed item specifies whether generics are acceptable and includes dosages tailored for specific medical procedures. The annual estimates reveal stable quantities necessary for operational consistency and highlights additional service costs such as after-hours delivery and call-out fees for pharmacists. The document serves a crucial role in enabling healthcare facilities and service providers to forecast their radiopharmaceutical needs, implement budgeting strategies, and streamline procurement processes, ensuring compliance with safety and regulatory standards associated with medical imaging and therapy. Overall, it underscores the federal government's initiative to facilitate the acquisition of essential medical isotopes in an organized, cost-effective manner.
    S02 36C26125R0033.pdf
    The document outlines a Request for Quotation (RFQ) issued by the Department of Veterans Affairs (VA) for the procurement of Non-Positron Emission Tomography (PET) Radiopharmaceuticals to support the Palo Alto Healthcare System. The solicitation highlights the requirements for licensed contractors to supply single unit doses of radiopharmaceuticals and associated materials with scheduled deliveries primarily on weekdays, and occasionally on weekends. The contract spans multiple fiscal years from 2025 to 2030, with each option allowing for continued service. Key requirements include strict compliance with regulatory standards, the provision of quality control measures, proper labeling of radioactive materials, and the ability to fulfill emergency requests. The document emphasizes the significance of timely and accurate deliveries to meet patient care needs, necessitating flexibility in order fulfillment. The structure encompasses sections detailing administrative data, a statement of work, pricing schedules, delivery schedules, and contractual clauses that govern the procurement process. There is a strong focus on small business participation and compliance with federal regulations. This RFQ reflects the government's ongoing commitment to supporting healthcare services provided to veterans and ensuring their safety through stringent contractor qualifications.
    Similar Opportunities
    6505--NEW IDIQ - NON Cyclotron Radiopharmaceuticals For time period covering FY 2025 through FY 2030
    Buyer not available
    The Department of Veterans Affairs is seeking qualified vendors to provide NON-Positron Emission Tomography (PET) Radiopharmaceuticals through a new Indefinite Delivery Indefinite Quantity (IDIQ) contract for the period covering Fiscal Years 2025 through 2030. The procurement aims to secure reliable and compliant supplies of prepared single doses of radiopharmaceuticals, adhering to strict quality and regulatory standards, with an emphasis on promoting small business participation in federal procurement. These radiopharmaceuticals are critical for supporting the healthcare services provided by the VA, ensuring timely delivery and compliance with safety regulations. Interested parties should contact Contract Specialist Edward Hunter at edward.hunter@va.gov for further details regarding the solicitation and requirements.
    6505--Radiopharmaceuticals Base Plus 4 Option Year IDIQ
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for an Indefinite Delivery Indefinite Quantity (IDIQ) contract for the procurement of radiopharmaceuticals, specifically Tc99m-derived products and related compounds, to be delivered to the Veterans Affairs Martinsburg Medical Center. The contract will commence on April 1, 2025, and includes a base year with four optional one-year extensions, concluding on March 31, 2030. These radiopharmaceuticals are critical for medical and diagnostic purposes within federal healthcare facilities, necessitating reliable delivery and compliance with strict safety and regulatory standards. Interested vendors must ensure they can meet the requirements for immediate orders, maintain quality control, and adhere to health regulations, with inquiries due by February 21, 2025, and responses by February 28, 2025. For further information, contact Contracting Officer Kami Hom at Kami.Hom@va.gov or by phone at 410-642-2411 x22404.
    Radiopharmaceuticals - Naval Medical Center Portsmouth
    Buyer not available
    The Department of Defense, through the Defense Health Agency, is soliciting proposals for the supply of radiopharmaceuticals to the Naval Medical Center Portsmouth. The procurement aims to secure a range of unit dose radiopharmaceuticals essential for cancer patient care, including isotopes such as Tc-99m, I-123, and F-18, with specific quantities and pricing outlined for various medical applications over multiple contract periods from 2026 to 2030. These radiopharmaceuticals play a critical role in diagnostic imaging and treatment, ensuring that healthcare providers have access to necessary medical supplies for effective patient care. Proposals are due by March 11, 2025, with inquiries accepted until February 17, 2025; interested vendors should contact Carol Uebelacker at carol.e.uebelacker.civ@health.mil or call 210-952-8111 for further details.
    6505--Ga68 NETSPOT Radiopharmaceuticals Corporal Michael J Crescenz VA Medical Center, Philadelphia, PA
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of NETSPOT Ga68 radiopharmaceuticals for the Corporal Michael J. Crescenz VA Medical Center in Philadelphia, PA. This procurement involves a firm-fixed-price contract for a 12-month period, commencing on June 4, 2025, and concluding on June 3, 2026, with a focus on supplying essential radiopharmaceuticals for imaging neuroendocrine tumors in adult patients. The selected vendor must be licensed by the Nuclear Regulatory Commission and adhere to strict delivery and regulatory standards, ensuring timely and compliant service. Interested vendors must submit their proposals by 10:00 AM EST on February 27, 2025, and can direct inquiries to Contract Specialist Christa Stine at christa.stine@va.gov or by phone at 570-824-3521.
    Q527--Y90 TheraSpheres OY3
    Buyer not available
    The Department of Veterans Affairs (VA) is issuing a Special Notice for a sole source procurement of Y90 TheraSpheres from Boston Scientific Corporation, aimed at extending an existing contract for an additional two years. This procurement involves the delivery of various calibrated doses of TheraSpheres, which are critical for specific medical treatments within the Veterans Health Administration (VHA). Interested parties are invited to express their interest and capabilities by February 28, 2025, although this notice does not constitute a request for competitive quotations; the decision for competitive procurement will depend on the responses received. For further inquiries, interested vendors should contact Contract Specialist Mariangie Rios Vazquez at mariangie.riosvazquez@va.gov or by phone at 210-996-8816.
    6525--DEC 2024 Equipment Only Consolidation
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of medical equipment under the solicitation titled "6525--DEC 2024 Equipment Only Consolidation." This initiative aims to acquire high-tech medical imaging equipment, specifically targeting the needs of the National Acquisition Center (NAC) for various healthcare facilities serving veterans. The procurement process is crucial for enhancing healthcare services, ensuring that the VA can provide state-of-the-art diagnostic and treatment capabilities. Key deadlines include the submission of vendor questions by February 19, 2025, and the final offer submission due by April 9, 2025. Interested vendors should direct inquiries to Contract Specialist Hermann A. Degbegni at hermann.degbegni@va.gov for further details.
    6505--Fluticasone Propionate 50 MCG/Spray Soln, Nasal, 16GM
    Buyer not available
    The Department of Veterans Affairs (VA) is preparing to issue a Request for Proposal (RFP) for the procurement of Fluticasone Propionate 50 MCG/Spray solution, nasal, 16GM, intended for use by various federal agencies including the Department of Defense, Bureau of Prisons, and Indian Health Service. The objective of this procurement is to secure a reliable and uninterrupted supply of this medication for a contract period of one year, with the possibility of four additional one-year extensions. This medication is crucial for treating nasal conditions, and the estimated annual requirement is approximately 5,784,828 bottles. The solicitation will be available electronically on or around February 11, 2025, with a closing date set for February 25, 2025. Interested vendors should direct inquiries to Michael Olszewski at michael.olszewski@va.gov or call 708-786-4966.
    6505--Rituximab and Biosimilars
    Buyer not available
    The Department of Veterans Affairs is soliciting proposals for the procurement of Rituximab 10mg/ml and its biosimilars, aimed at establishing a reliable pharmaceutical supply source for government healthcare facilities. Bidders are required to provide unique National Drug Code (NDC) numbers for their products and include a 0.5% Cost Recovery Fee in their pricing, with the contract covering a base year and four optional subsequent years. This procurement is critical for ensuring consistent product availability and pricing based on estimated annual usage, while adhering to FDA regulations and the Drug Supply Chain Security Act (DSCSA) for safety and traceability. Interested suppliers must submit their proposals by March 11, 2025, at 2:30 PM CT, and can contact Contract Specialist Deborah S Fassl at Deborah.Fassl@va.gov for further information.
    6525--646-25-2-233-0228 | Water Phantom | NCO 4 Commodities 2 (VA-25-00042337)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for the procurement of a water phantom package intended for commissioning and quality assurance of Linear Accelerators (LINAC) at the Veterans Affairs Medical Center in Pittsburgh, Pennsylvania. The solicitation, identified as 36C24425Q0378, outlines specific requirements for the water phantom, including automated capabilities and compatibility with Varian TrueBeam® LINAC systems. This procurement is crucial for ensuring the quality and effectiveness of medical equipment used in patient care. Interested vendors must submit their quotations by February 28, 2025, at 16:00 EST, and are required to provide compliance certifications and a Letter of Authorization from the Original Equipment Manufacturer (OEM). For further inquiries, potential offerors can contact Nathan Lohr at nathan.lohr@va.gov or by phone at 412-628-3595.
    Q522 - Teleradiology Services for Oklahoma City VA Health Care System (OKCVAHCS)
    Buyer not available
    The Department of Veterans Affairs is seeking proposals for Teleradiology Services to support the Oklahoma City VA Health Care System (OKCVAHCS). The contract, estimated at $19 million, requires the contractor to provide off-site radiological interpretations, ensuring compliance with standards set by the American College of Radiology, and to maintain timely communication regarding abnormal findings. This procurement is critical for enhancing healthcare delivery to veterans by providing efficient access to radiology expertise, particularly during off-hours. Interested parties should contact Fanta M Cooper-Wells at fanta.cooper-wells@va.gov, with the performance period scheduled from March 1, 2025, to February 28, 2026, and options for extension available.